Keyword Analysis & Research: next science limited
Keyword Research: People who searched next science limited also searched
Search Results related to next science limited on Search Engine
-
Next Science - Breakthrough Technologies for the Problem of Biofilm
https://www.nextscience.com/
WEBNov 4, 2021 · Next Science is a medical device company that pioneers innovative technologies to address one of the leading causes of antimicrobial resistance, bacterial biofilms.
DA: 51 PA: 81 MOZ Rank: 91
-
Next Science | Investor Centre
https://investors.nextscience.com/investor-centre/
WEBApr 17, 2024 · Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human …
DA: 48 PA: 3 MOZ Rank: 84
-
About Next Science - Next Science
https://www.nextscience.com/about-next-science/
WEBA Proven Solution to Biofilm. Our unwavering commitment to innovation and cutting-edge technology led us to apply material science principles to address, and ultimately resolve, one of the leading causes of antimicrobial resistance, bacterial biofilms.
DA: 2 PA: 61 MOZ Rank: 6
-
Next Science Ltd (ASX:NXS) Share Price - Market Index
https://www.marketindex.com.au/asx/nxs
WEBApr 19, 2019 · Today’s NXS share price, stock chart and announcements. View dividend history, insider trades and ASX analyst consensus.
DA: 67 PA: 35 MOZ Rank: 78
-
Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse
https://www.businesswire.com/news/home/20210811005702/en/Next-Science-Begins-U.S.-Clinical-Trial-for-XPERIENCE-No-Rinse-Antimicrobial-Solution
WEBAug 11, 2021 · JACKSONVILLE, Fla.-- ( BUSINESS WIRE )-- Next Science Limited (ASX:NXS) ( Next Science / Company) is pleased to announce that a clinical trial has been initiated in the U.S. for XPERIENCE...
DA: 62 PA: 9 MOZ Rank: 53
-
Next Science Ltd (NXS) Stock Price & News - Google Finance
https://www.google.com/finance/quote/NXS:ASX
WEBnextscience.com. Get the latest Next Science Ltd (NXS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
DA: 78 PA: 35 MOZ Rank: 60
-
2021 ANNUAL REPORT - Next Science
https://investors.nextscience.com/DownloadFile.axd?file=/Report/ComNews/20220422/02512599.pdf
WEBApr 22, 2022 · Sydney, Australia, Friday, 22 April 2022: Next Science Limited (ASX:NXS) today releases its 2021 Annual Report. A copy of the 2021 Annual Report, as well as a copy of the Notice of Meeting for the 2022 AGM and an Online Meeting Guide, are available on Next Science’s website at:
DA: 79 PA: 18 MOZ Rank: 23
-
Next Science Ltd, NXS:ASX profile - FT.com - Financial Times
https://markets.ft.com/data/equities/tearsheet/profile?s=NXS:ASX
WEBApr 5, 2024 · Next Science Limited is an Australia-based medical technology company. The Company’s primary focus is on the development and commercialization of its proprietary XBIO technology to reduce the...
DA: 37 PA: 13 MOZ Rank: 55
-
Next Science | LinkedIn
https://www.linkedin.com/company/nextscience
WEBJacksonville, FL. Type. Public Company. Founded. 2012. Specialties. Biotechnology, Biofilm eradication, Healthcare, infection prevention, wound care, antimicrobial, surgical site infection, and...
DA: 19 PA: 95 MOZ Rank: 85
-
Next Science Ltd, NXS:ASX summary - FT.com - Financial Times
https://markets.ft.com/data/equities/tearsheet/summary?s=NXS:ASX
WEBApr 8, 2024 · Key statistics. On Monday, Next Science Ltd (NXS:ASX) closed at 0.335, 86.11% above the 52 week low of 0.18 set on Oct 30, 2023. 52-week range. Today. 0.18 Oct 30 2023 0.775 Apr 14 2023....
DA: 42 PA: 75 MOZ Rank: 76
